Lessons learned for pandemic preparedness in the neurodegenerative research and clinical fields: an advice report based on Parkinson’s disease as an example.

Publication date: Dec 05, 2024

A sustainable pandemic preparedness strategy is essential to ensure equitable access to healthcare for individuals with neurodegenerative diseases. Moreover, it is vital to provide clinicians and researchers in the neurodegenerative disease fields with resources and infrastructure to ensure continuity of their work during a (health) crisis. We established an international collaboration between researchers, clinicians, and patient representatives from the Netherlands, Poland, and the United Kingdom. We co-created a pandemic preparedness plan primarily informed by examples from those affected by or working in the field of Parkinson’s disease, with potential application to other neurodegenerative diseases or the general population. This plan builds upon insights and experiences from four population-based studies during the COVID-19 pandemic. Between March and November 2023, we organised two hybrid meetings in Bristol (United Kingdom) and Rotterdam (the Netherlands), and two online meetings. Research recommendations included three core factors in questionnaire design during health crises: 1) using existing, validated questions, 2) questionnaire adaptability and flexibility, and 3) testing within and outside the research group. Additionally, we addressed burden of participation, and we advocated for robust data sharing practices, underlining the importance of regulatory measures extending beyond the COVID-19 pandemic. We also shared clinical perspectives, including strategies to mitigate social isolation; challenges in virtual versus in-person consultations; and systemic changes to recognise and prevent moral injury in healthcare professionals. In this pandemic preparedness plan, we provide research and clinical recommendations tailored to the field of Parkinson’s disease, with broader relevance to other neurodegenerative diseases and the general population. This establishes an essential framework for setting up new studies and safeguarding research and clinical practices when a new pandemic or other (health) crisis emerges.

Open Access PDF

Concepts Keywords
Healthcare Biomedical Research
Neurodegenerative Cohort study
Poland COVID-19
Sustainable COVID-19
Healthcare utilisation
Humans
Netherlands
Neurodegenerative Diseases
Neurodegenerative diseases
Pandemic Preparedness
Pandemic preparedness
Pandemics
Parkinson Disease
Poland
SARS-CoV-2
Surveys and Questionnaires
United Kingdom

Semantics

Type Source Name
disease MESH Parkinson’s disease
disease MESH neurodegenerative diseases
pathway REACTOME Neurodegenerative Diseases
disease MESH COVID-19 pandemic
disease MESH moral injury
pathway REACTOME Reproduction
disease MESH dementia
disease MESH parkinsonism
drug DRUGBANK Coenzyme M
disease MESH cognitive impairments
disease MESH recurrence
drug DRUGBANK Medical air
disease MESH infectious diseases
disease MESH chronic diseases
disease MESH infection
drug DRUGBANK Methylergometrine
disease MESH home environment
disease IDO process
disease IDO quality
disease MESH life style
drug DRUGBANK Isoxaflutole
disease MESH privacy
drug DRUGBANK Trestolone
disease MESH gait
disease MESH educational attainment
disease MESH psychological trauma
disease MESH burnout
disease MESH psychological well being
drug DRUGBANK Tretamine
drug DRUGBANK Gold
disease MESH Stroke
drug DRUGBANK Methionine
drug DRUGBANK Etodolac
drug DRUGBANK Tropicamide
drug DRUGBANK Troleandomycin
pathway KEGG Parkinson disease

Original Article

(Visited 1 times, 1 visits today)